August 27, 2026
Tag: Pengda Liu
August 4, 2026
FirstWord Pharma: UNC Biochemists Discover New Method to Combat Pediatric Bone Cancer

August 3, 2026
UNC biochemists discover new method to combat pediatric bone cancer
Pengda Liu, PhD, and colleagues are investigating a new way to tackle Ewing sarcoma, an aggressive and rare pediatric cancer that develops in the bones and soft tissues, while minimizing toxicity typically associated with chemotherapy.

July 12, 2026
Liu Lab receives Maia James Sarcoma Innovation Grant Award
Pengda Liu, PhD, was awarded $40,000 from the Strides for Sarcoma Foundation to support his work developing novel antibody-drug conjugates to facilitate the clinical translation of new targeted therapies for Ewing sarcoma.

July 7, 2026
Advancing new Ewing sarcoma therapy
Xiaodong Wang, PhD, and Pengda Liu, PhD, were awarded a $3.8 million NCI grant to develop a promising targeted treatment for a rare and aggressive pediatric cancer.

December 1, 2025
Priming the pump for new cancer treatments
UNC Eshelman School of Pharmacy’s Chemical Biology and Medicinal Chemistry Division is a central hub for cancer therapeutics. Its faculty members are studying the chemical and biological mechanisms that promote cancer growth and persistence.

November 1, 2025
UNC researchers unlock new way to help fight skin cancer
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR-T therapy to better fight off melanoma.

April 29, 2025
Researchers develop molecule that targets Ewing sarcoma
Pengda Liu, PhD, and colleagues have created a small molecule that targets and breaks down a protein linked to Ewing sarcoma, an aggressive cancer that mostly affects children and teens.

April 18, 2025
UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.

October 22, 2024
Researchers identify new protein pathway, biological function important for cell migration, cancer metastasis
Pengda Liu, PhD, and colleagues have identified an unexpected biological function of 2’3’-cGAMP, one that can facilitate cell migration and how cancer spreads.